Today, we are joined by Dr. Bin Cao, the vice director of the National Clinal Research Center for Respiratory Diseases in the Peoples Republic of China. In this episode, we discuss Dr. Cao's paper published in The New England Journal of Medicine titled, "A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19".

Thanks for joining us for this wonderful opportunity to learn from one of the leading researchers on the COVID pandemic. Enjoy!

Talking Points:

• About this podcast and our mission (0:00)
• Dr. Cao's describes his journey treating COVID-19 (1:10)
• Who discovered COVID-19? (1:35)
• The first month in Wuhan (2:12)
• Past experiences in clinical research (3:20)
• The three independent risk factors of COVID (5:28)
• Treatment for SARS and the relationship to COVID-19 (7:17)
• Advice for healthcare workers (8:40)
• Issues with vaccine development and next steps (11:00)
• Antibody-dependent enhancement (11:53)
• Final thoughts (13:00)

Resources: "A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19" The New England Journal of Medicine. 2020 May 7. https://pubmed.ncbi.nlm.nih.gov/32187464/